8-KEarnings & ResultsExhibits & Filings

BIOGEN INC. 8-K Report, Financial Results (Jul 29, 2026)

Filed July 29, 2026For Securities:BIIB

Summary

Biogen Inc. (BIIB) has filed a Form 8-K on July 29, 2026, to announce its financial results for the second quarter ended June 30, 2026. The primary purpose of this filing is to furnish a press release detailing the company's operational and financial performance during the period. Investors should refer to the furnished press release (Exhibit 99.1) for specific details on revenue, earnings, and other key financial metrics, as well as any forward-looking statements or guidance provided by the company. While the 8-K itself is brief, it signifies the official release of Biogen's quarterly performance data. It's crucial for investors to access and analyze the accompanying press release for a comprehensive understanding of the company's recent financial health, strategic updates, and outlook. The information provided in the press release will be instrumental in evaluating Biogen's current standing and future prospects within the biotechnology sector.

Key Highlights

  • 1Biogen Inc. announced its second quarter 2026 financial results on July 29, 2026.
  • 2The results were disclosed via a press release furnished as Exhibit 99.1 to the 8-K filing.
  • 3Investors are directed to the press release for detailed financial and operational performance data.
  • 4The filing does not contain specific financial figures within the 8-K text itself.
  • 5This report serves as notification of the release of Q2 2026 earnings information.

Frequently Asked Questions

The actual financial results are detailed in the press release furnished as Exhibit 99.1 to this Form 8-K filing. You should refer to that document for specific revenue, earnings, and other financial performance data.

The 8-K filing does not specify the key financial metrics. Investors need to consult the press release (Exhibit 99.1) for information on revenue, net income, earnings per share, and any other relevant financial or operational highlights from the second quarter of 2026.

No, the press release furnished as Exhibit 99.1 is being furnished pursuant to Item 2.02 and shall not be deemed 'filed' for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that Section. It also won't be deemed incorporated by reference in any other filing unless expressly stated.